FDA Grants Orphan Drug Designation to CNP-104 for Primary Biliary Cholangitis
The designation follows positive topline data from the phase 2a trial of CNP-104 in PBC, which were presented at AASLD’s The Liver Meeting
Related Articles
wqow.com
Eau Claire breaking news, weather and live video. Covering local politics, crime, health, education and sports for Eau Claire and the Chippewa Valley in Wisconsin.
Calls for Papers
Discovery Immunology is an open access journal covering novel discoveries in cellular and molecular immunology, brought to you by the British Society
Bayer Submits Finerenone Application to FDA for Treatment of Heart Failure
Submission of the supplemental NDA was based on positive findings from the FINEARTS-HF trial investigating finerenone for heart failure with an LVEF ≥40%.
Disney Donates $15 Million to L.A Fires Relief and Rebuilding Efforts
The Walt Disney Company has committed $15 million to relief and rebuilding efforts for communities impacted by the ongoing L.A. fires.
42-year-old Commodore 64 is still hard at work in a US shop
At 42 years old, the legendary Commodore 64 is still hard at work managing the finances of a bakery shop in the US.
Do smoking bans work?
Since 2007 there have been moves towards stricter regulations on smoking in public spaces across the world. But have any of these had noticeable health…
Want a quick daily podcast based on your interests? Try Google’s latest AI experiment
Dubbed Daily Listen, a podcast hosted by two AI chatbots will discuss topics based on your search and Discover activities on Google.
How AI will transform cybersecurity in 2025 – and supercharge cybercrime
From AI-driven defense to evolving ransomware tactics, here’s what cybersecurity industry leaders and experts are preparing for this year.
I tested an ink pen that records your handwriting and makes a digital copy. Spoiler: It works
The Nuwa Pen utilizes three tiny cameras to capture what you write – on paper! – and save your notes in an accompanying app. I…
I took a 90-second vision test at CES 2025, and the results were surprisingly accurate
The Eyebot kiosk had long lines every day. After trying it, I understood why.